Medical Cannabis

Table of Contents
    Add a header to begin generating the table of contents

    Medical Cannabis is Medicine

    At present 24 states allow cannabis for medicinal use. There are hundreds of chemical compounds in cannabis that work together to provide therapy for an array of conditions and symptoms. We all have receptors for and produce natural endocannabinoids which help our bodies with internal stability and health. Consumed Cannabinoids help communicate between cells and bind to receptors in the nervous system both in the brain (CB-1 receptors) and the body (CB-2 receptors). Depending on the strain, concentration, and many other factors, cannabis can have both positive and negative effects.

    Medical Cannabis is Medicine

    The history of marijuana as recognized medicine 1850 - present

    1850

    The US pharmacopeia admitted marijuana as a recognized medicine in 1850 under the name of
    Extractium Cannabis or Extract of Hemp and listed it until 1942.

    1937

    In 1937 a federal law was
    passed against cannabis, despite the objections of the American Medical Association (AMA) at the time.

    1976

    In 1976 the federal
    government created the investigational New Drug Compassionate Access Research Program to allow patients to receive access to cannabis, paid for by the federal government.

    1988

    In 1988 the
    Chief DEA Administrative Law Judge ruled after extensive hearings that, “Marijuana, in its natural form, is one of the safest therapeutically active substances known.”

    1996

    In 1996 states began
    passing voter initiatives that allowed for legal use with a doctor’s recommendation.

    1997

    In 1997 the
    Office of National Drug Control Policy commissioned the Institute of Medicine (IOM) to conduct
    a comprehensive study of cannabis Therapeutics. The IOM concluded that cannabis was a safe
    and effective medicine, patients should have access, and the government should expand
    avenues for research and drug development.

    If you feel that Medical Cannabis is something that you think may benefit your specific situation,
    please discuss it with your primary care provider. It is always best to consume products for
    medical use from a dispensary so that you are sure it is tested and safe. We always recommend
    starting at a low dose and going slow to give time for effects and see if it is helpful. You may
    have to trial products to find the best match for your specific condition and your
    receptors. You may find a good match that is helpful for you or a loved one. Many people find
    great benefits from this modality, and it should be considered as treatment without negative
    connotations if a patient is considering it.

    Medical Cannabis Patient Certification

    Kelly DeFeo CRNA, FNP, PhD has provided Anesthesia and pain management in the North Country for over 24 years. She was appointed to the NH Therapeutic Advisory Council that implemented the Therapeutic Cannabis Program in NH. She owns Cranmore Health Partners and provides Pain Management services to the North Country Community. She currently certifies patients in both NH and ME for Qualifying conditions. 

    Kelly DeFeo

    Standalone Medical conditions:

    Autism Spectrum Disorder

    Autism spectrum disorder (ASD)

    • (age 21 or older); Autism Spectrum Disorder (under 21) requires consultation with a certified provider of child and/or adolescent psychiatry, developmental pediatrics, or pediatric neurology, who 
      • 1. Confirms ASD has not responded to previously prescribed medications or that other treatment options produced serious side effects and 
      • 2. Supports certification for the use of therapeutic cannabis. 
    Moderate to severe PTSD

    Moderate to severe PTSD

    Moderate to severe chronic pain

    Moderate to severe chronic pain

    Severe pain

    Severe pain

    Opioid use disorder with associated symptoms of cravings or withdrawal

    Opioid use disorder with associated symptoms of cravings or withdrawal

    (requires a provider who is actively treating the patient for opioid use disorder and who is board-certified in Addiction Medicine or Addiction Psychiatry. 

    Combination of a Qualifying Dx (Qualifying Diagnosis) AND a Qualifying Symptom

     Qualifying Conditions include

    Acquired Immune deficiency syndrome

    Acquired Immune deficiency syndrome

    Alzheimer’s disease

    Alzheimer’s disease

    Severe pain

    Amyotrophic lateral sclerosis

    Cancer

    Cancer

    Chronic pancreatitis

    Chronic pancreatitis

    Crohn’s disease

    Crohn’s disease

    Ehlers-Danlos syndrome

    Ehlers-Danlos syndrome

    Epilepsy

    Epilepsy

    Glaucoma

    Glaucoma

    Hepatitis C

    Hepatitis C

    Lupus

    Lupus

    Multiple Sclerosis

    Multiple Sclerosis

    Muscular dystrophy

    Muscular dystrophy

    Parkinson’s disease

    Parkinson’s disease

    Spinal cord injury or disease

    Spinal cord injury or disease

    Traumatic brain injury

    Traumatic brain injury

    Ulcerative colitis

    Ulcerative colitis

    one or more injuries or condition that has resulted in one or more qualifying symptoms

    One or more injuries or condition that has resulted in one or more qualifying symptoms

    Qualifying Symptoms

    Agitation of Alzheimer’s disease

    Agitation of Alzheimer’s disease

    Cachexia

    Cachexia

    Chemotherapy-induced anorexia

    Chemotherapy-induced anorexia

    Constant or severe nausea

    Constant or severe nausea

    Elevated intraocular pressure

    Elevated intraocular pressure

    Moderate to severe insomnia

    Moderate to severe insomnia

    Moderate to severe vomiting

    Moderate to severe vomiting

    Seizures

    Seizures

    Severe pain

    Severe pain

    Severe and persistent muscle spasms

    Severe and persistent muscle spasms

    Wasting syndrome

    Wasting syndrome

    Scroll to Top